The Trump administration said it will limit approval for seasonal COVID-19 shots to seniors and others at high risk pending ...

The FDA said moving forward, it will adopt a framework requiring proof that a vaccine can generate antibodies in people over ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

A new FDA framework for Covid-19 vaccines created confusion among physicians about what it means for young children ...

Moderna, Inc. (NASDAQ:MRNA) shares soared to the top of the S&P 500 gainers in early afternoon trading on May 20, surging by ...

The US Food and Drug Administration is changing the way it approves Covid-19 vaccines for Americans — a move that will limit ...

The FDA says the new approach will aim to balance a timely approval process for vaccines, while also weighing “the need for evidence" of their effectiveness for the masses.

COVID vaccines are only approved for elderly and a few others as RFK continues to reshape how Americans fight disease - ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...